These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 38483177)
1. Exploring the Antibacterial Activity and Cellular Fates of Enterobactin-Drug Conjugates That Target Gram-Negative Bacterial Pathogens. Guo C; Nolan EM Acc Chem Res; 2024 Apr; 57(7):1046-1056. PubMed ID: 38483177 [TBL] [Abstract][Full Text] [Related]
2. Conjugation to Native and Nonnative Triscatecholate Siderophores Enhances Delivery and Antibacterial Activity of a β-Lactam to Gram-Negative Bacterial Pathogens. Motz RN; Guo C; Sargun A; Walker GT; Sassone-Corsi M; Raffatellu M; Nolan EM J Am Chem Soc; 2024 Mar; 146(11):7708-7722. PubMed ID: 38457782 [TBL] [Abstract][Full Text] [Related]
3. Investigation of Siderophore-Platinum(IV) Conjugates Reveals Differing Antibacterial Activity and DNA Damage Depending on the Platinum Cargo. Guo C; Wang KA; Nolan EM ACS Infect Dis; 2024 Apr; 10(4):1250-1266. PubMed ID: 38436588 [TBL] [Abstract][Full Text] [Related]
4. Siderophore-mediated cargo delivery to the cytoplasm of Escherichia coli and Pseudomonas aeruginosa: syntheses of monofunctionalized enterobactin scaffolds and evaluation of enterobactin-cargo conjugate uptake. Zheng T; Bullock JL; Nolan EM J Am Chem Soc; 2012 Nov; 134(44):18388-400. PubMed ID: 23098193 [TBL] [Abstract][Full Text] [Related]
5. Heavy-Metal Trojan Horse: Enterobactin-Directed Delivery of Platinum(IV) Prodrugs to Guo C; Nolan EM J Am Chem Soc; 2022 Jul; 144(28):12756-12768. PubMed ID: 35803281 [TBL] [Abstract][Full Text] [Related]
7. Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity. Neumann W; Sassone-Corsi M; Raffatellu M; Nolan EM J Am Chem Soc; 2018 Apr; 140(15):5193-5201. PubMed ID: 29578687 [TBL] [Abstract][Full Text] [Related]
8. Enterobactin-mediated delivery of β-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli. Zheng T; Nolan EM J Am Chem Soc; 2014 Jul; 136(27):9677-91. PubMed ID: 24927110 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a reducible disulfide linker for siderophore-mediated delivery of antibiotics. Neumann W; Nolan EM J Biol Inorg Chem; 2018 Oct; 23(7):1025-1036. PubMed ID: 29968176 [TBL] [Abstract][Full Text] [Related]
10. The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport. Abergel RJ; Clifton MC; Pizarro JC; Warner JA; Shuh DK; Strong RK; Raymond KN J Am Chem Soc; 2008 Aug; 130(34):11524-34. PubMed ID: 18680288 [TBL] [Abstract][Full Text] [Related]
11. Enterobactin-specific antibodies inhibit in vitro growth of different gram-negative bacterial pathogens. Wang H; Zeng X; Lin J Vaccine; 2020 Nov; 38(49):7764-7773. PubMed ID: 33164800 [TBL] [Abstract][Full Text] [Related]
12. Exploring the Localization of Siderophore-Mediated Cargo Delivery in Gram-Negative Bacteria Using 3-Hydroxypyridin-4(1 Huang YJ; Yang MH; Lin LY; Liu J; Zang YP; Lin J; Chen WM ACS Infect Dis; 2024 Jun; 10(6):2303-2317. PubMed ID: 38725130 [TBL] [Abstract][Full Text] [Related]
13. Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Chairatana P; Zheng T; Nolan EM Chem Sci; 2015 Aug; 6(8):4458-4471. PubMed ID: 28717471 [TBL] [Abstract][Full Text] [Related]
14. Siderophores as drug delivery agents: application of the "Trojan Horse" strategy. Möllmann U; Heinisch L; Bauernfeind A; Köhler T; Ankel-Fuchs D Biometals; 2009 Aug; 22(4):615-24. PubMed ID: 19214755 [TBL] [Abstract][Full Text] [Related]
15. Location, Location, Location: Establishing Design Principles for New Antibacterials from Ferric Siderophore Transport Systems. Luo VC; Peczuh MW Molecules; 2024 Aug; 29(16):. PubMed ID: 39202968 [TBL] [Abstract][Full Text] [Related]
16. Hijacking of the Enterobactin Pathway by a Synthetic Catechol Vector Designed for Oxazolidinone Antibiotic Delivery in Moynié L; Hoegy F; Milenkovic S; Munier M; Paulen A; Gasser V; Faucon AL; Zill N; Naismith JH; Ceccarelli M; Schalk IJ; Mislin GLA ACS Infect Dis; 2022 Sep; 8(9):1894-1904. PubMed ID: 35881068 [TBL] [Abstract][Full Text] [Related]
17. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria. Diarra MS; Lavoie MC; Jacques M; Darwish I; Dolence EK; Dolence JA; Ghosh A; Ghosh M; Miller MJ; Malouin F Antimicrob Agents Chemother; 1996 Nov; 40(11):2610-7. PubMed ID: 8913474 [TBL] [Abstract][Full Text] [Related]